In the BioHarmony Drug Report Database
Panitumumab
Vectibix (panitumumab) is an antibody pharmaceutical. Panitumumab was first approved as Vectibix on 2006-09-27. It is used to treat colorectal neoplasms in the USA. It has been approved in Europe to treat colorectal neoplasms. The pharmaceutical is active against epidermal growth factor receptor.
Trade Name
|
Vectibix |
|---|---|
Common Name
|
panitumumab |
ChEMBL ID
|
CHEMBL1201827 |
Indication
|
colorectal neoplasms |
Drug Class
|
Monoclonal antibodies |
Image (chem structure or protein)
